Cullinan Oncology, Inc. CGEM | $130.33M | 13.27 | 7.65M | 0% | +$0 | 21.09 | |
Werewolf Therapeutics, Inc. HOWL | $15.47M | 5.5 | 2.39M | 0% | +$0 | 2.51 | |
Sutro Biopharma, Inc. STRO | $23.15M | 5.01 | 4.1M | New | +$23.15M | 3.75 | |
iTeos Therapeutics, Inc. ITOS | $23.81M | 4.83 | 1.75M | 0% | +$0 | 3.86 | |
Repare Therapeutics Inc. RPTX | $7.72M | 3.86 | 1.64M | 0% | +$0 | 1.25 | |
Olema Pharmaceuticals, Inc. OLMA | $22.12M | 3.49 | 1.95M | +5.2% | +$1.09M | 3.58 | |
Xeris Biopharma Holdings, Inc. XERS | $9.21M | 2.81 | 4.17M | +8.3% | +$705,573.43 | 1.49 | |
ALX Oncology Holdings Inc. ALXO | $14.14M | 2.44 | 1.27M | +0.29% | +$41,388.80 | 2.29 | |
Zentalis Pharmaceuticals, Inc. ZNTL | $23.9M | 2.13 | 1.52M | New | +$23.9M | 3.87 | |
Adaptimmune Therapeutics plc ADAP | $8.05M | 1.99 | 5.1M | 0% | +$0 | 1.3 | |
Trevi Therapeutics, Inc. TRVI | $4.63M | 1.9 | 1.34M | New | +$4.63M | 0.75 | |
Fulcrum Therapeutics, Inc. FULC | $10.73M | 1.83 | 1.14M | New | +$10.73M | 1.74 | |
KalVista Pharmaceuticals, Inc. KALV | $9.02M | 1.8 | 760,722 | New | +$9.02M | 1.46 | |
Geron Corporation GERN | $34.57M | 1.77 | 10.48M | -2.24% | -$791,818.51 | 5.6 | |
Compass Therapeutics, Inc. CMPX | $3.9M | 1.43 | 1.97M | New | +$3.9M | 0.63 | |
REGENXBIO Inc. RGNX | $11.57M | 1.12 | 549,078 | 0% | +$0 | 1.87 | |
89bio, Inc. ETNB | $11.26M | 0.98 | 967,742 | New | +$11.26M | 1.82 | |
Viridian Therapeutics, Inc. VRDN | $10.75M | 0.96 | 614,010 | +514.01% | +$9M | 1.74 | |
Avadel Pharmaceuticals plc AVDL | $14.71M | 0.91 | 871,149 | +31% | +$3.48M | 2.38 | |
Iovance Biotherapeutics, Inc. IOVA | $32.6M | 0.79 | 2.2M | -33.12% | -$16.15M | 5.28 | |
Verve Therapeutics, Inc. VERV | $8.47M | 0.76 | 638,163 | 0% | +$0 | 1.37 | |
Morphic Holding, Inc. MORF | $11.45M | 0.65 | 325,333 | +0.49% | +$56,003.20 | 1.85 | |
Relay Therapeutics, Inc. RLAY | $6.91M | 0.63 | 832,017 | 0% | +$0 | 1.12 | |
Crinetics Pharmaceuticals, Inc. CRNX | $22.5M | 0.61 | 480,588 | +0.49% | +$110,190.74 | 3.64 | |
Akero Therapeutics, Inc. AKRO | $8.41M | 0.48 | 332,924 | New | +$8.41M | 1.36 | |
Edgewise Therapeutics, Inc. EWTX | $8.05M | 0.47 | 441,259 | New | +$8.05M | 1.3 | |
MoonLake Immunotherapeutics MLTX | $14.87M | 0.46 | 296,050 | +0.5% | +$74,039.02 | 2.41 | |
Intellia Therapeutics, Inc. NTLA | $11.9M | 0.45 | 432,598 | +13.07% | +$1.38M | 1.93 | |
Disc Medicine, Inc. IRON | $6.9M | 0.45 | 110,779 | +121.56% | +$3.78M | 1.12 | |
Insmed Incorporated INSM | $14.4M | 0.36 | 530,794 | +0.5% | +$71,731.72 | 2.33 | |
Ultragenyx Pharmaceutical Inc. RARE | $11.47M | 0.3 | 245,590 | New | +$11.47M | 1.86 | |
Madrigal Pharmaceuticals, Inc. MDGL | $16.4M | 0.29 | 61,399 | +50.08% | +$5.47M | 2.65 | |
Amicus Therapeutics, Inc. FOLD | $8.47M | 0.24 | 718,970 | +0.43% | +$36,364.86 | 1.37 | |
Axsome Therapeutics, Inc. AXSM | $9.11M | 0.24 | 114,127 | +22.21% | +$1.66M | 1.47 | |
Revolution Medicines, Inc. RVMD | $8.81M | 0.17 | 273,217 | -0.07% | -$6,155.93 | 1.43 | |
Natera, Inc. NTRA | $15.77M | 0.14 | 172,413 | New | +$15.77M | 2.55 | |
Viking Therapeutics, Inc. VKTX | $12.3M | 0.14 | 150,000 | -53.89% | -$14.37M | 1.99 |